Search

everythinglearnresearchcommunity

for

Search:↓

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Mice without active or present vitamin D receptors maintain normal blood sugar control and islet gene expression when calcium levels are normal.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

HAT-MSCs can effectively engulf harmful microbes and particles, aiding infection treatment.

The new hair graft device is faster, more efficient, and reduces damage to hair follicles.

The VDR gene polymorphism does not affect BDNF levels in autoimmune thyroiditis and hypothyroidism patients.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Blood metabolites significantly influence alopecia areata risk.

Standardized tools and treatments are needed to better manage long COVID-19 in kids and teens.

Both Unani treatments effectively reduced hair shedding in Telogen Effluvium.

Higher prolactin levels are linked to psoriasis, alopecia areata, and vitiligo severity.

Combining NdYag laser with pulsed light effectively treats rosacea with manageable side effects.

NFAT5 triggers atherosclerosis under stress by activating inflammation in blood vessels.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Plant-derived amino acids can help develop new antimicrobial drugs.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Fat under the skin releases HGF which helps hair grow and gain color.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Genetic discoveries are leading to new treatments for alopecia areata.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Standardized PRP is effective for tendinopathies, with most patients improving after one injection.

Cannabis has anti-inflammatory and antimicrobial properties, but more research is needed on its effects on plant and aquatic animal pathogens.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.